PLO | 1.61 [1.12,2.23] | NA | NA | NA | 2.16 [1.14, 3.76] |
NA | CAR | NA | NA | NA | 1.39 [0.66, 2.60] |
1.44 [1.10, 1.88] | NA | OLA | NA | NA | NA |
2.04 [1.70, 2.44] | NA | 1.45 [1.02, 1.99] | QUE | NA | NA |
1.03 [0.75, 1.39] | NA | 0.73 [0.47, 1.06] | 0.51 [0.35, 0.72] | ZIP | NA |
2.20 [1.35, 3.40] | NA | 1.56 [0.86, 2.53] | 1.09 [0.64, 1.73] | 2.19 [1.21, 3.64] | LUR |
- Note: Remission defined as MADRS ≤10 results are on the top-right and Remission defined as MADRS ≤12 results are on the bottom-left. Numbers represent the odds ratio [95% credible interval]. In the top-right comparisons, the row treatment is the reference category. In the bottom-left, the column treatment is the reference category. Studies that used alternative definitions were not included: the aripiprazole studies and one quetiapine study defined remission as MADRS ≤8 at endpoint
- Abbreviations: PLO Placebo, CAR Cariprazine, LUR Lurasidone, OLA Olanzapine, QUE Quetiapine, ZIP Ziprasidone
